Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | 2.0 | - |
Min SIP Amount | ₹500 | - |
Expense Ratio | 2.25 | - |
NAV | ₹22.46 | - |
Fund Started | 17 Dec 2018 | - |
Fund Size | ₹53.51 Cr | - |
Exit Load | - | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 19.38% | - |
3 Year | 15.15% | - |
5 Year | 15.01% | - |
1 Year
3 Year
5 Year
Equity | 93.76% | - |
Cash | 6.15% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
---|---|
Sun Pharmaceutical Industries Ltd. | 3.30% |
Trent Ltd. | 3.15% |
Bharti Airtel Ltd. | 2.98% |
Bosch Ltd. | 2.74% |
Lupin Ltd. | 2.57% |
Torrent Pharmaceuticals Ltd. | 2.48% |
ICICI Bank Ltd. | 2.36% |
Glenmark Pharmaceuticals Ltd. | 2.34% |
HCL Technologies Ltd. | 2.31% |
Divi's Laboratories Ltd. | 2.31% |
Name | Gargi Bhattacharyya Banerjee | - |
Start Date | 21 Nov 2019 | - |
Name
Start Date
Description | The Scheme seeks to generate income and long-term capital appreciation from a diversified portfolio of predominantly equity and equity related securities and enable investors to avail the income tax rebate, as permitted from time to time. | - |
Launch Date | 17 Dec 2018 | - |
Description
Launch Date